Freestone Grove Partners »

Supernus Pharmaceuticals shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $9.8M 196k 49.70